# Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI

> **NCT01781715** · PHASE4 · UNKNOWN · sponsor: **Russian Academy of Medical Sciences** · enrollment: 120 (estimated)

## Conditions studied

- ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

## Interventions

- **DEVICE:** Zotarolimus-eluting coronary stent

## Key facts

- **NCT ID:** NCT01781715
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2013-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781715, "Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01781715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*